Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Annovis Bio Inc (ANVS)

Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Annovis Bio Inc 101 Lindenwood Drive Suite 225 Malvern PA 19355 USA

www.annovisbio.com Employees: 8 P: 484-875-3192

Sector:

Medical

Description:

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 97,001
Enterprise Value, $K 86,451
Shares Outstanding, K 26,503
Annual Sales, $ 0 K
Annual Net Income, $ -24,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,260 K
EBIT, $ -26,710 K
EBITDA, $ -26,710 K
60-Month Beta 1.49
% of Insider Shareholders 20.80%
% of Institutional Shareholders 15.83%
Float, K 20,990
% Float 79.20%
Short Interest 2,829
Short Float 10.68%
Short Volume Ratio 0.30

Growth:

1-Year Return -30.23%
3-Year Return -72.75%
5-Year Return -51.46%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/12/25
Next Earnings Date 03/20/26
Earnings Per Share ttm -1.44
EPS Growth vs. Prev Qtr -15.63%
EPS Growth vs. Prev Year 61.86%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANVS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -153.50%
Return-on-Assets % -125.51%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.65
Book Value/Share 0.54
Interest Coverage -2.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar